Target intelligence / Profile preview

Japanese Encephalitis Virus Antigen (JEV Antigen)

Target: JEV Antigen
Molecular classification: Viral protein, Antigen, Glycoprotein (E protein), Structural protein (C, M, E), Nonstructural protein (NS1-NS5)

Overview

Japanese encephalitis virus (JEV) antigen refers to the various proteins of the virus that elicit an immune response in the host. The envelope (E) protein is the primary antigenic determinant and the main target for neutralizing antibodies and vaccine development. Other structural proteins include the capsid (C) and membrane (M) proteins, while non-structural proteins (NS1-NS5) play roles in viral replication and immune evasion. The E protein mediates viral attachment and fusion, making it crucial for viral entry and a key target for therapeutic intervention and diagnostic assays.

Other names: JEVJapanese Encephalitis VirusJEV E proteinJEV structural proteinsJEV Envelope ProteinJEV Capsid ProteinJEV Membrane Protein

Mechanism of action

Vaccines target the E protein to stimulate neutralizing antibody production, preventing viral entry and infection.

Biological functions

Viral entryHost cell attachmentMembrane fusionImmunogenicityInduction of neutralizing antibodiesViral replicationImmune evasion

Disease associations

Japanese EncephalitisViral encephalitisInfection

Safety considerations

Potential for incomplete cross-protection between JEV genotypesImmune evasion mechanisms of JEVRisk of vaccine-associated adverse events (rare)

Biomarkers

JEV-specific IgGJEV-specific IgM

Beyond the preview

Go deeper on Japanese Encephalitis Virus Antigen (JEV Antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Japanese Encephalitis Virus Antigen (JEV Antigen).

Explore the full profile